Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-28

Clinical Trial Update: Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage - a Prospective Randomized Open Blinded End-point Trial [Phase 4]

View source ↗

Summary

Phase 4 prospective randomized blinded-endpoint trial assessing the safety and feasibility of Cerebrolysin for treating primary intracerebral hemorrhage; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cerebrolysin

Snippet

Sponsor: Cardinal Stefan Wyszynski University | Conditions: Intracerebral Hemorrhage, Hemorrhagic Stroke, Intracerebral | Phase 4 | Status: NOT_YET_RECRUITING